Mild isolate of Tomato Brown Rugose Fruit Virus (Tobago-R23)

The mild isolate of tomato brown rugose fruit virus (Tobago-R23) is a biological agent designed to induce cross-immunity in tomato plants. This isolate is an attenuated version of the pathogen that does not cause severe symptoms, allowing the plant to develop a protective immune response.

The mode of action relies on the principle of cross-protection, where the pre-exposure of a plant to a mild strain prevents the subsequent infection by a more virulent strain of the same virus.

Once the plant is inoculated with Tobago-R23, its physiological defense systems are primed and prepared to recognize and suppress the replication of the aggressive field-strain of ToBRFV.

This biological vaccination approach significantly mitigates the risk of total crop loss, which is typical for highly susceptible tomato varieties under severe ToBRFV pressure.

By integrating this isolate into a management program, growers can maintain plant health and productivity despite the pervasive presence of the virus in the environment.

This product is exclusively intended for protecting tomato crops (Solanum lycopersicum) against the destructive Tomato brown rugose fruit virus (ToBRFV).

ToBRFV is known for its extreme virulence and rapid transmission, making it a critical threat to greenhouse tomato production worldwide.

The immunization aims to protect both the vegetative growth of the plant and the development of high-quality fruits, which are otherwise often deformed and non-marketable when infected with ToBRFV.

The application is aimed at professional growers who operate in high-risk areas where traditional containment and sanitation methods are insufficient.

Effective immunization helps secure the supply chain by ensuring that plants can continue to produce commercial-grade fruit under virus-challenged conditions.

Vaccination is typically performed at the seedling stage, specifically at the two-to-four true leaf stage, to ensure systemic resistance prior to transplanting.

The application procedure requires precise timing and uniform coverage to ensure that all plants receive an adequate dose of the mild isolate.

Growers must strictly follow the manufacturer's technical protocols regarding inoculation methods to achieve the desired level of protection.

Monitoring for successful inoculation is essential to verify that the plants have developed the necessary immune status before entering the production greenhouse.

Following vaccination, crop management should focus on maintaining optimal environmental conditions to support the plant's metabolic capacity during the immune response period.

The use of Tobago-R23 requires strict regulatory compliance as it involves the intentional introduction of a viral pathogen into the agro-ecosystem.

Application is prohibited in areas where ToBRFV is not present to prevent the unintentional spread of the virus into virus-free zones.

Rigorous hygiene protocols must be implemented to prevent mechanical transmission of the isolate to susceptible non-vaccinated crops or neighboring fields.

Operators must be trained in handling biological plant protection agents to minimize the risk of accidental exposure or mishandling.

Any unexpected disease progression or failure in immunity must be reported to the appropriate agricultural authorities for investigation and management.